Globus Medical reported second-quarter worldwide net sales of $789.6 million, up 5.9% year over year, and raised its full-year non-GAAP diluted earnings per share guidance while reaffirming its 2026 revenue outlook.
GAAP net income in Q2 fell 25.3% year over year to $151.6 million, according to an Aug. 6 news release from the medtech company. Globus attributed this decrease to a one-time $110.5 million gain from its Nevro acquisition in 2025.
The company increased its full-year non-GAAP diluted EPS guidance to $4.95 to $5.05 from its previous range of $4.70 to $4.80, and it reaffirmed its revenue guidance of $3.18 billion to $3.22 billion.
Globus reported second-quarter non-GAAP diluted EPS of $1.34, up 55.8% year over year. Worldwide net sales increased 5.9%, driven by a 3.0% increase in U.S. net sales and an 18.0% increase in international net sales.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
